CONTENTS
Summer 2024
Discovery and development
14. How public/private partnerships in genomics are streamlining patient pathways and delivering value
Since the completion of the Human Genome Project in 2003, there has been huge growth in the utilisation of genomics, but how can partnerships in this area be used to improve patient experience
20. Next-generation size selection: accelerating the pace of gene synthesis in drug discovery and development
Synthetic biology has been a cornerstone in recent health advancements, including drug discovery, development and manufacturing, however there are challenges facing this market
Digital
29. Innovation can play a key role in Scotland’s fight to reduce ‘pandemic of frailty’
Frailty should not be considered an inevitability, but the effects can be significant. How can technological innovations combat this?
Manufacturing
36. Protein-based immunotherapies – the journey from discovery to manufacturing
Protein-based immunotherapies are reshaping oncology treatments, but ensuring their safety and efficacy is crucial for their success
42. Addressing the UK Government's new initiative on medical device equity
Medical devices should be designed with an awareness of the challenges around a specific disease as well as an awareness of equality, but how will this impact medical device production going forward?
44. The role of protein synthesis in drug discovery and development
How can protein synthesis be used within the discovery and manufacturing of new drugs and how can it be automated?
Lab automation
48. The journey to full automation – for labs of all sizes
With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?
Microscopy
18. elmi2024: Thanks to all our attendees and sponsors!
RMS reflects on a fantastic week in Liverpool
Features
8. The key to formulation development is in the details
How can a thorough approach to tablet manufacturing reduce manufacturing issues, costs and downtime?
12. ACHEMA 2024 sets the tone for a more sustainable and competitive process industry
ACHEMA 2024 took place 10-14 June 2024 in Frankfurt, Germany, with 2,842 exhibitors from 56 nations
23. 17th European Microscopy Congress to take place in Copenhagen, Denmark
EMC2024 is the 17th European Microscopy Congress, taking place in Copenhagen, Denmark from Sunday 25 August to Friday 30 August
34. Ilmac Lausanne 2024 – The largest meeting place of the chemical and life sciences industry in French-speaking Switzerland
On 18 and 19 September 2024, Ilmac will be held at the Expo Beaulieu Lausanne, Switzerland
Regulars
6. Editorial desk
This issue brings you the latest innovations in the field of pharma, from AI to medtech and genomics
54. Events
IPT's events page shows off some of the most exciting events this summer season has to offer
Index of Advertisers
IFC. RMS
5. Achema
17. EMC
31. ELRIG
33. ILMAC
37. BIO-Europe
41. London Biotech
41. IPT Online
47. CPHI Milan
49. FlyPharma Europe
53. Samedan Ltd
IBC. INTERPHEX
OBC. Natoli
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Iona Everson
EDITOR
Charlie Blackie-Kelly
DEPUTY EDITORS
James Spargo
Natalia Elliot
EDITORIAL ASSISTANTS
Betsy Goodfellow
SALES
Louise Wilson-English
DESIGN
Peter May
FRONT COVER
Shutterstock
DIGITAL EDITION
IPT Online
www.iptonline.com
CONTACT US
Tel: +44 (0)20 7724 3456
PRINTING
Pureprint Group
www.pureprint.com
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2024 Samedan Ltd
Pharmaceutical Publishers